跳至主要内容
临床试验/IRCT20191211045693N1
IRCT20191211045693N1招募中3 期

Effects of compound Ma-ol-asal syrup on cancer-related fatigue in gastrointestinal (GI) cancer patients who are undergoing chemotherapy

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 78 years(—)
性别
All

入选标准

  • 1.Age between 18- 70 years old
  • 2. GI cancer (pathologically diagnosed)
  • 3.Undergoing chemotherapy
  • 4. Hemoglobin level at least 10g/dl
  • 5. Hematocrit level at least 30% .
  • 6. No clinical symptom of hypothyroidism
  • 7. Visual Analogue Fatigue Scale (VAS)>=4

排除标准

  • 1. Heart disease with unstable conditions
  • 2. Liver disease with unstable conditions
  • 3. Disabling pulmonary disease
  • 4. Positive history of hypersensitivity to honey and its compounds
  • 5. Positive history of hypersensitivity to each component of the compound Ma-ol-asal syrup.
  • 6. Uncontrolled pain.
  • 7. An individual who uses treatment due to known psychiatric disease
  • 8.Pregnancy.
  • 9. Simultaneous use of drugs that affect fatigue.
  • 10. kidney disease with unstable conditions
  • 11. Severe infection
  • 12. Serious accompanying disease.

研究者

相似试验